Resources
Please follow the links below to our online systems and breach report form
- TRuST – Randomisation or Emergency Unblinding
- Castor Data Management System – eCRF
- Tayside Pharmacovigilance System – SAE reporting
- Breach Reporting Form – TASC SOP59
Templates
TASC SOPs
- TASC SOP11 – Identifying, Recording and Reporting AEs for CTIMPs
- TASC SOP59 – Reporting Breaches in Clinical Research
Training Presentations
- Introduction V1
- Identifying Participants & Eligibility Criteria V3
- Randomisation V2
- Emergency Unblinding V2
- Visits V2
- Assessments including Working Practice Guidelines V2
- Concomitant medications V2
- Source Data V1
- Laboratory Samples V2
- IMP Management and Accountability V1
- Data Collection Data Entry V1
- Risk and Adverse Events Overview V2
- Breach Reporting V1
- Discontinuation, Withdrawal, Completion V2
- AM11 Summary V1
Manuals and User Guides
- Laboratory Manual V6
- Pharmacy Manual V4
- Castor User Guide – Data Entry Guidelines V1
- TRuST User Guide V1
- Pharmacovigilance Database User Guide V5
Protocol and Participant Materials
- Protocol V6
- Brief Participant Information Sheet V1 – Template
- Participant Information Sheet V7-Template
- Informed Consent Form V4 – Template
- GP Letter V2 – Template
- Invite Letter (Clinic and GP) V1– Template
- Invite Letter (Database) V1 – Template
- Advert Poster V1 – Template
- CMR Sub-study Participant Information Sheet V1
- CMR Sub-study Informed Consent Form V1
- CMR Sub-study GP Letter V1
Continuation Sheets
Worksheets
- Visits Dates Calculator V1
- Adverse Events V1
- Concomitant Medication V2
- Hypoglycaemic Events V1
- Diabetic Ketoacidosis (DKA) Events V1
- Eligibility Form V3
- Blood Glucose and Ketones Diary V1
- Insulin Dose Diary V1
- Discontinuation of Trial Medication V1
- Completion/Early Withdrawal V1
- Visit 1 V3
- Visit 2 V1
- Visit 3 V3
- Visit 4 V2
- Visit 5 V2
- Visit 6 V2
- Visit 7 V2
- Visit 8 V2
